Vascular Biogenics Financial Statements Trends

VBLT -- USA Stock  

USD 1.60  0.05  3.23%

This module enables investors to look at Vascular Biogenics various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Vascular Biogenics Valuation or Volatility. It can also complement various Vascular Biogenics Technical models. Also please take a look at analysis of Vascular Biogenics Correlation with competitors.

Current Liabilities Analysis

Current Liabilities is company's short term debts. This usually includes obligations that are due within next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Vascular Biogenics 
Current Liabilities 
Accrued Debt 
4.16 M

About Current Liabilities

Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare to competition
In accordance with recently published financial statements Vascular Biogenics Ltd has Current Liabilities of 4.16 M. This is 99.62% lower than that of the Healthcare sector, and 99.47% lower than that of Biotechnology industry, The Current Liabilities for all stocks is 99.99% higher than the company.

Vascular Biogenics Fundamental Drivers Relationships

Vascular Biogenics Ltd is rated below average in cash flow from operations category among related companies. It is rated below average in return on equity category among related companies .

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Vascular Biogenics Fundamental Drivers

Vascular Biogenics Ltd Fundamental Market Drivers

Forward Price Earnings-2.16
Short Percent Of Float2.64%
Average Daily Volume Last 10 Day157.37k
Shares Short Prior Month394.5k
Average Daily Volume In Three Month216.4k
Date Short InterestJune 15, 2018
Fifty Day Average2.057
Two Hundred Day Average3.131

Vascular Biogenics Upcoming Events

Vascular Biogenics Upcoming Company Events

Upcoming Quarterly ReportApril 4, 2017
Next Earnings ReportMay 12, 2017
Also please take a look at analysis of Vascular Biogenics Correlation with competitors. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.